Hillsdale Investment Management’s Axcelis ACLS Stock Holding History

Hillsdale Investment Management’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-30	Closed	-$3.89K	–	585
2023 Q4	$3.89K	Hold	30	–	–	﹤0.01%	552
2023 Q3	$4.89K	Buy	30 +10	+50%	+$1.76K	﹤0.01%	521
2023 Q2	$3.67K	Sell	20 -6,680	-100%	-$962K	﹤0.01%	486
2023 Q1	$893K	Sell	6,700 -36,900	-85%	-$4.34M	0.08%	188
2022 Q4	$3.46M	Sell	43,600 -58,300	-57%	-$4.11M	0.29%	130
2022 Q3	$6.17M	Buy	101,900 +7,900	+8%	+$510K	0.56%	40
2022 Q2	$5.16M	Buy	94,000 +500	+0.5%	+$29K	0.41%	67
2022 Q1	$7.06M	Sell	93,500 -600	-0.6%	-$41K	0.46%	49
2021 Q4	$7.02M	Buy	+94,100	New	+$5.58M	0.47%	48
2021 Q1	–	Sell	-38,400	Closed	-$1.12M	–	527
2020 Q4	$1.12M	Hold	38,400	–	–	0.11%	197
2020 Q3	$845K	Buy	+38,400	New	+$979K	0.08%	224
2018 Q1	–	Sell	-51,200	Closed	-$1.47M	–	463
2017 Q4	$1.47M	Hold	51,200	–	–	0.24%	68
2017 Q3	$1.4M	Hold	51,200	–	–	0.24%	70
2017 Q2	$1.07M	Buy	+51,200	New	+$1.08M	0.21%	91

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hillsdale Investment Management's ACLS Position: Q1 2024 in Review

Hillsdale Investment Management sold out of Axcelis (ACLS) in Q1 2024, closing a stake of 30 shares — an estimated $3.89K sold.

Hillsdale Investment Management first reported a position in ACLS in Q2 2017 and held it in 14 quarters. The position peaked at $7.06M in Q1 2022. 385 funds tracked by Wall St. Rank hold ACLS as of Q1 2024.

Hillsdale Investment Management reported no remaining Axcelis position as of Q1 2024 after selling out during the quarter.
Hillsdale Investment Management sold 30 Axcelis shares in Q1 2024, an estimated $3.89K.
Hillsdale Investment Management first reported a position in Axcelis in Q2 2017 and held it in 14 quarters.
Hillsdale Investment Management's Axcelis position peaked at $7.06M in Q1 2022.
385 funds tracked by Wall St. Rank held Axcelis as of Q1 2024.

Based on Hillsdale Investment Management's 13F filing for Q1 2024, filed 10 May 2024.